According to VistaGen Therapeutics 's latest financial reports the company's current earnings (TTM) are -$33.79 M. In 2022 the company made an earning of -$63.72 M a decrease over its 2021 earnings that were of -$37.29 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$33.79 M | -46.98% |
2022 | -$63.72 M | 70.9% |
2021 | -$37.29 M | 149.03% |
2020 | -$14.98 M | -39.09% |
2019 | -$24.58 M | 7.16% |
2018 | -$22.94 M | 34.78% |
2017 | -$17.02 M | 7.87% |
2016 | -$15.78 M | -62.22% |
2015 | -$41.76 M | 518.34% |
2014 | -$6.76 M | -4.87% |
2013 | -$7.1 M | -36.51% |
2012 | -$11.19 M | 48.41% |
2011 | -$7.54 M | 84117.81% |
2010 | -$0.01 M | -59.28% |
2009 | -$0.03 M | 34.07% |
2008 | -$0.02 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 227.92% | ๐บ๐ธ USA |